Catalyst Pharmaceuticals
CPRX
#3582
Rank
NZ$4.56 B
Marketcap
$37.46
Share price
-0.04%
Change (1 day)
46.06%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2023 (TTM): $1.80

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.83. In 2022 the company made an earnings per share (EPS) of $1.33 an increase over its 2021 EPS that were of $0.63.

EPS history for Catalyst Pharmaceuticals from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.8035.29%
2022$1.33110.53%
2021$0.63-47.22%
2020$1.20132.26%
2019$0.52-191.18%
2018-$0.5754.55%
2017-$0.37-4.35%
2016-$0.38-8%
2015-$0.424.17%
2014-$0.40-11.11%
2013-$0.45107.69%
2012-$0.22-55.17%
2011-$0.4831.82%
2010-$0.37-55.1%
2009-$0.82-39.51%
2008-$1.35145.45%
2007-$0.55-8.33%
2006-$0.60-28.71%
2005-$0.84180.56%
2004-$0.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.30-29.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.03-811.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.44 1,180.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.27-988.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.10 69.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.95 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA